Abeona Therapeutics Inc.

Abeona Therapeutics Inc. - PE Ratioverified

ABEO

Price:

$5.77

Market Cap:

$328.86M

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epidermolysis bullosa. The company's pipeline also features several other promising therapies: ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A. ABO-201, intended for CLN3 disease. ABO-401, developed to treat cystic fibrosis. ABO-50X, aimed at various genetic eye disorders. Additionally, Abeona is advancing AAV-b...[Read more]

Industry

Biotechnology

IPO Date

1980-09-19

Stock Exchange

NASDAQ

Ticker

ABEO

The PE Ratio as of June 2026 (TTM) for Abeona Therapeutics Inc. (ABEO) is 6.07

According to Abeona Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 6.07. This represents a change of -219.66% compared to the average of -5.07 of the last 4 quarters.

Abeona Therapeutics Inc. (ABEO) Historical PE Ratio (quarterly & annually)

How has ABEO PE Ratio performed in the past?

The mean historical PE Ratio of Abeona Therapeutics Inc. over the last ten years is -4.42. The current 6.07 PE Ratio has changed -13835.04% with respect to the historical average. Over the past ten years (40 quarters), ABEO's PE Ratio was at its highest in in the June 2024 quarter at 5.53. The PE Ratio was at its lowest in in the September 2017 quarter at -32.19.

Quarterly (TTM)
Annual

Average

-4.42

Median

-2.06

Minimum

-24.16

Maximum

3.93

Abeona Therapeutics Inc. (ABEO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Abeona Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 255.54%

Maximum Annual PE Ratio = 3.93

Minimum Annual Increase = -209.44%

Minimum Annual PE Ratio = -24.16

Quarterly (TTM)
Annual
YearPE RatioChange
20253.93-209.44%
2024-3.5981.47%
2023-1.98255.54%
2022-0.5640.88%
2021-0.40-77.08%
2020-1.73-19.66%
2019-2.15-64.14%
2018-5.99-75.22%
2017-24.16218.83%
2016-7.5818.72%

Abeona Therapeutics Inc. (ABEO) Average PE Ratio

How has ABEO PE Ratio performed in the past?

The current PE Ratio of Abeona Therapeutics Inc. (ABEO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.55

5-year avg

-0.52

10-year avg

-4.42

Abeona Therapeutics Inc. (ABEO) PE Ratio vs. Peers

How is ABEO’s PE Ratio compared to its peers?

Abeona Therapeutics Inc.’s PE Ratio is greater than Tenaya Therapeutics, Inc. (-1.55), greater than Eledon Pharmaceuticals, Inc. (-4.51), less than Puma Biotechnology, Inc. (15.24), greater than Humacyte, Inc. (-1.57), greater than Voyager Therapeutics, Inc. (-1.88), greater than Arcturus Therapeutics Holdings Inc. (-2.66), greater than Foghorn Therapeutics Inc. (-3.55), greater than Sagimet Biosciences Inc. (-4.95), greater than Assembly Biosciences, Inc. (-42.14),

Build a custom stock screener for Abeona Therapeutics Inc. (ABEO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abeona Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abeona Therapeutics Inc. (ABEO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abeona Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Abeona Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Abeona Therapeutics Inc. (ABEO)?

What is the highest PE Ratio for Abeona Therapeutics Inc. (ABEO)?

What is the 3-year average PE Ratio for Abeona Therapeutics Inc. (ABEO)?

What is the 5-year average PE Ratio for Abeona Therapeutics Inc. (ABEO)?

How does the current PE Ratio for Abeona Therapeutics Inc. (ABEO) compare to its historical average?